Register Cart 0

Generic placeholder image

Current Enzyme Inhibition

Editor-in-Chief

ISSN (Print): 1573-4080
ISSN (Online): 1875-6662

Back Subscribe

Preface

Preface

Author(s): D. Hadjipavlou-Litina

Volume 9, Issue 1, 2013

Page: [i - i] Pages: 1

DOI: 10.2174/1573408011309010001

Price: $65

« Previous

Rights & Permissions Print Cite

Article Metrics

8

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Conformational Diseases: Structural Studies of Aggregation of Polyglutamine Proteins
Current Computer-Aided Drug Design

Altering the Tropism of Lentiviral Vectors through Pseudotyping
Current Gene Therapy

Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
Current Medicinal Chemistry

Glycogen Metabolism and Brain Pathologies
Central Nervous System Agents in Medicinal Chemistry

Structural Properties of the NMDA Receptor and the Design of Neuroprotective Therapies
Mini-Reviews in Medicinal Chemistry

Potential Application of Centrifuges to Protect the CNS in Space and on Earth
Current Alzheimer Research

The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets

A Common Biological Mechanism in Cancer and Alzheimers Disease?
Current Alzheimer Research

Astrocytes: From the Physiology to the Disease
Current Alzheimer Research

Aggregation Prone Regions and Gatekeeping Residues in Protein Sequences
Current Topics in Medicinal Chemistry

Neurodegenerative Disorders and the Current State, Pathophysiology, and Management of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets

Amyloid-Related Biomarkers for Alzheimers Disease
Current Medicinal Chemistry

Stimuli-Responsive Nanocarriers for Drug Delivery to the Central Nervous System
Current Nanoscience

Non-Steroidal Anti-Inflammatory Drugs as Anti-Amyloidogenic Compounds
Current Pharmaceutical Design

The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders
Central Nervous System Agents in Medicinal Chemistry

Turning REST/NRSF Dysfunction in Huntingtons Disease into a Pharmaceutical Target
Current Pharmaceutical Design

Therapeutic Strategies for the Treatment of Spinal Muscular Atrophy (SMA) Disease
Current Genomics

Personalized Drug Discovery: HCA Approach Optimized for Rare Diseases at Tel Aviv University
Combinatorial Chemistry & High Throughput Screening

Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System
Recent Patents on CNS Drug Discovery (Discontinued)

Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings
Current Molecular Pharmacology

© 2024 Bentham Science Publishers | Privacy Policy